IMRN

Immuron (IMRN)

Immuron Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMRN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/05	19 : 12	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2024/05/31	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2024/05/31	19 : 00	GlobeNewswire Inc.	Immuron Board Changes	NASDAQ:IMRN	Immuron Ltd
2024/05/31	19 : 00	GlobeNewswire Inc.	Immuron CEO Steven Lydeamore to present at Peak Sky High	NASDAQ:IMRN	Immuron Ltd
2024/05/03	19 : 00	GlobeNewswire Inc.	Immuron Director Resignation	NASDAQ:IMRN	Immuron Ltd
2024/04/15	19 : 00	GlobeNewswire Inc.	Immuron to host Live Virtual Event	NASDAQ:IMRN	Immuron Ltd
2024/04/10	19 : 00	GlobeNewswire Inc.	Immuron Travelan® sales continued strong growth	NASDAQ:IMRN	Immuron Ltd
2024/03/07	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2024/03/07	20 : 00	GlobeNewswire Inc.	Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	NASDAQ:IMRN	Immuron Ltd
2024/02/28	22 : 08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2024/02/21	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2024/02/21	20 : 00	GlobeNewswire Inc.	Immuron Presentation Australian Biologics Festival 2024	NASDAQ:IMRN	Immuron Ltd
2024/02/13	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2024/02/13	20 : 00	GlobeNewswire Inc.	Immuron achieves record Travelan® sales	NASDAQ:IMRN	Immuron Ltd
2024/02/08	20 : 00	GlobeNewswire Inc.	Immuron CEO, Steven Lydeamore Investor Webinar Presentation	NASDAQ:IMRN	Immuron Ltd
2024/01/16	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2024/01/16	20 : 00	GlobeNewswire Inc.	Immuron achieves record half yearly Travelan® sales	NASDAQ:IMRN	Immuron Ltd
2023/12/22	21 : 21	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2023/12/22	20 : 00	GlobeNewswire Inc.	Immuron Clinical Trials Update	NASDAQ:IMRN	Immuron Ltd
2023/12/04	20 : 32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2023/12/04	20 : 00	GlobeNewswire Inc.	Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	NASDAQ:IMRN	Immuron Ltd
2023/11/28	20 : 33	GlobeNewswire Inc.	Immuron CEO, Steven Lydeamore Investor Webinar Presentation	NASDAQ:IMRN	Immuron Ltd
2023/11/28	20 : 17	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2023/11/22	21 : 16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2023/11/21	20 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2023/11/14	08 : 00	GlobeNewswire Inc.	Immuron CEO Steven Lydeamore Investor Webinar Presentation	NASDAQ:IMRN	Immuron Ltd
2023/11/13	22 : 28	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2023/10/30	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd
2023/10/30	20 : 21	GlobeNewswire Inc.	Immuron CEO Steven Lydeamore presented at AusBioInvest	NASDAQ:IMRN	Immuron Ltd
2023/10/23	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMRN	Immuron Ltd